Nuclear magnetic resonance contrast agents
Patent
·
OSTI ID:563675
A family of contrast agents for use in magnetic resonance imaging and a method of enhancing the contrast of magnetic resonance images of an object by incorporating a contrast agent of this invention into the object prior to forming the images or during formation of the images. A contrast agent of this invention is a paramagnetic lanthanide hexaazamacrocyclic molecule, where a basic example has the formula LnC{sub 16}H{sub 14}N{sub 6}. Important applications of the invention are in medical diagnosis, treatment, and research, where images of portions of a human body are formed by means of magnetic resonance techniques. 10 figs.
- Research Organization:
- University of California
- Sponsoring Organization:
- USDOE, Washington, DC (United States)
- DOE Contract Number:
- W-7405-ENG-36
- Assignee:
- Dept. of Energy, Washington, DC (United States)
- Patent Number(s):
- US 5,702,683/A/
- Application Number:
- PAN: 7-643,092
- OSTI ID:
- 563675
- Country of Publication:
- United States
- Language:
- English
Similar Records
Nuclear magnetic resonance contrast agents
Intravascular contrast agents suitable for magnetic resonance imaging. [Dogs]
Precipitation of gadolinium from magnetic resonance imaging contrast agents may be the Brass tacks of toxicity
Patent
·
Tue Dec 31 23:00:00 EST 1996
·
OSTI ID:871291
Intravascular contrast agents suitable for magnetic resonance imaging. [Dogs]
Journal Article
·
Mon Oct 01 00:00:00 EDT 1984
· Radiology; (United States)
·
OSTI ID:6334724
Precipitation of gadolinium from magnetic resonance imaging contrast agents may be the Brass tacks of toxicity
Journal Article
·
Fri Mar 07 23:00:00 EST 2025
· Magnetic Resonance Imaging
·
OSTI ID:2584370